기업 윤리적 딜레마용 AI 도구

집

AI 프롬프트 목록

철학/종교

윤리적 의사결정 지원

${:__('collect %s',윤리적 의사결정 지원)}$

철학/종교

비즈니스 운영의 구체적인 윤리적 딜레마에 대해 공리주의와 의무론에 기반한 포괄적인 분석 프레임워크를 제공하여 관리자가 도덕적으로 견고한 결정을 내리도록 지원합니다.

프롬프트 내용

복사

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.

복사

다음 비즈니스 운영에서 마주하는 구체적인 윤리적 딜레마를 분석하십시오: 제약 회사가 시판 중인 약물의 희귀한 부작용이 장기 복용 시 심각한 건강 위험을 초래할 수 있음을 발견했지만, 회수하면 회사가 파산하고 수천 명의 직원들의 생계가 위협되며, 은폐하면 환자 안전 원칙을 위반합니다. 공리주의의 최대 다수의 최대 행복 관점과 개인의 권리와 성실한 의무를 존중하는 의무론적 관점을 결합하여 공개 공개, 부분 회수, 완전 은폐의 세 가지 옵션의 도덕적 무게를 평가하고, 사회적 책임과 기업의 생존을 균형 있게 취하면서 의사결정 과정이 투명하고 비즈니스 윤리 규범을 준수하도록 보장하는 구체적인 행동 권고를 제공하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

윤리적 의사결정 지원

Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.

윤리적 의사결정 지원

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.

윤리적 의사결정 지원

Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.

윤리적 의사결정 지원

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.

윤리적 의사결정 지원

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.